SCM
MRNA icon

Segantii Capital Management’s Moderna MRNA Stock Holding History

Segantii Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-325,000
Closed -$20.9M – 69
2020
Q2 		$20.9M Buy
+325,000
New +$17.8M 1.47% 19
2020
Q1 		– Sell
-1,091,815
Closed -$21.4M – 85
2019
Q4 		$21.4M Buy
+1,091,815
New +$19.4M 1.55% 13

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Segantii Capital Management's MRNA Position: Q3 2020 in Review

Segantii Capital Management sold out of Moderna (MRNA) in Q3 2020, closing a stake of 325,000 shares — an estimated $20.9M sold.

Segantii Capital Management first reported a position in MRNA in Q4 2019 and held it in 2 quarters. The position peaked at $21.4M in Q4 2019. 547 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

  • Segantii Capital Management reported no remaining Moderna position as of Q3 2020 after selling out during the quarter.
  • Segantii Capital Management sold 325,000 Moderna shares in Q3 2020, an estimated $20.9M.
  • Segantii Capital Management first reported a position in Moderna in Q4 2019 and held it in 2 quarters.
  • Segantii Capital Management's Moderna position peaked at $21.4M in Q4 2019.
  • 547 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on Segantii Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.